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Purpose: Several studies suggest that postnatal ocular growth is under the control of factors within the eye that regulate
the rate of scleral extracellular matrix remodeling and the rate of ocular elongation. A microarray analysis was employed
to identify some of the factors involved in the regulation of visually guided ocular growth. Gene expression was compared
in the retina-retinal pigmented epithelium (RPE)-choroid of chick eyes that were decelerating in the rate of ocular growth
(“recovering” from myopia) as compared with contralateral control eyes.
Methods: Form-deprivation myopia was induced in the right eyes of two-day-old chicks by the application of translucent
occluders. Following 10 days of deprivation, occluders were removed and chicks were provided unrestricted vision for
an additional 1–7 days (recovery). After one and four days of recovery, chicks were sacrificed, retina, RPE, and choroid
were isolated, and mRNA was subjected to microarray analysis using a chicken immune system 4000 gene microarray.
In addition, whole eyes and isolated ocular tissues (retina and RPE, choroid, sclera, and extraocular muscle) of treated
and control eyes were subjected to real-time PCR, immunohistochemistry, and western blot analyses to verify gene
expression results.
Results: Following one day of recovery, only one gene, avian thymic hormone (ATH) was highly upregulated (+12.3
fold). ATH gene and protein expression were confirmed in the retina and choroid as well as in the sclera and extraocular
muscle. A significant increase in ATH protein was detected in choroids from treated eyes following four days of recovery
as compared to contralateral controls (p<0.05; Wilcoxon signed-rank test).
Conclusions: ATH is expressed in several ocular tissues and is specifically and rapidly (within one day) upregulated in
the choroids of chick eyes recovering from induced myopia. This upregulation corresponds to the onset of choroidal
thickening and increased choroidal vascular permeability. The identification of ATH in ocular tissues and its increased
protein accumulation in the choroid during recovery from induced myopia suggest a novel role for this protein in the
choroidal response to myopic defocus.
Myopia is a common ocular problem, affecting perhaps
one billion people worldwide [1]. Most myopia is produced
by lengthening of the vitreous chamber of the ocular globe,
which generally stabilizes after puberty. However, failure of
ocular  elongation  to  stabilize  results  in  scleral  thinning,
localized ectasia of the posterior sclera, retinal thinning, and
possibly retinal detachment [2].
Animal  models  of  myopia  have  provided  significant
insights into the cellular and molecular events underlying the
control of ocular elongation and the refractive state. Depriving
the retina of form vision by lid suture or translucent occluders
(form deprivation), or by imposing hyperopic defocus on the
retina  with  the  use  of  minus  lenses  [3,4]  results  in  an
accelerated rate of axial elongation and a relative negative
refractive  error  in  the  treated  eye  as  compared  with  the
contralateral  untreated  eye  (relative  myopia).  In  contrast,
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exposure  to  myopic  defocus,  as  a  result  of  restoration  of
unrestricted  vision  in  previously  form-deprived  eyes
(recovery)  or  treatment  with  plus  lenses  results  in  a
decelerated rate of axial elongation and positive refractive
error  as  compared  with  the  contralateral  untreated  eye
(relative  hyperopia).  Significant  changes  in  scleral
extracellular matrix synthesis, accumulation, and turnover are
associated with changes in vitreous chamber elongation rates
during the development of experimentally induced myopia or
hyperopia  in  a  variety  of  animals  [5].  Although  the
mechanisms underlying visually guided changes in ocular
elongation have yet to be determined, it is widely accepted
that intrinsic factors within the eye play an important role in
these scleral remodeling events [6]. Several laboratories have
observed  that  the  choroid  undergoes  dramatic  changes  in
thickness and vascular permeability in response to changes in
the visual environment [7–10]. When young chicks are fitted
with translucent occluders to deprive the retina of form vision,
choroidal  thickness  and  permeability  are  reduced  in  the
deprived  eye,  coincident  with  increased  eye  growth  and
myopia development. When the occluder is removed, and
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778unrestricted  vision  is  restored  in  chicks  (“recovery”),
choroidal  thickness  and  vascular  permeability  are  greatly
increased and the rate of ocular growth in the treated eye is
greatly decreased. We hypothesize that changes in choroidal
thickness  are  the  consequence  of  increased  choroidal
permeability [9]. These changes in choroidal thickness and
permeability  are  suggested  to  provide  a  mechanism  for
compensating  for  induced  changes  in  refractive  error  by
moving the retina closer to the focal point of the eye [7].
Choroidal thickness and permeability changes may be the
result of changes in choroidal blood flow [11], changes in the
production  of  osmotically  active  molecules,  such  as
glycosaminoglycans that draw water into lymphatic lacunae
present in the choroidal stroma [7,12], or by the contraction
and relaxation of nonvascular smooth muscle cells present
within the choroidal stroma [13,14]. Moreover, these ocular
growth  changes  are  largely  mediated  by  an  unknown
mechanism within the eye; changes in choroidal thickness and
associated ocular growth changes occur in the absence of an
intact optic nerve [15]. Similar changes in choroidal thickness
have been observed in marmoset and macaques, but to a lesser
degree [16,17].
While several recent reports have described gene and
protein  expression  changes  in  retina  and  retina–retinal
pigmented epithelium (RPE) associated with visually induced
changes in ocular growth [18–20], no previous studies have
examined gene or protein expression changes in the choroid
during visually induced changes in ocular growth. Therefore,
as  a  first  step  in  elucidating  any  molecular  mechanism
associated with the choroidal response during the recovery
from induced myopia, we employed microarray analyses to
compare gene expression in chick retina together with retinal
pigmented  epithelium  and  choroid  (retina–RPE–choroid)
isolated from eyes experiencing myopic defocus as a result of
prior form deprivation (recovering eyes) with contralateral
untreated  eyes.  Using  microarray  analysis  together  with
subsequent real time PCR, immunohistochemical and western
blot analyses of the individual ocular tissues, for the first time
we have identified the protein, avian thymic hormone (ATH),
in several chick ocular tissues. Moreover, mRNA and protein
levels of ATH appear to be significantly upregulated in the
choroid during the recovery from induced myopia. Together,
these results suggest that ATH may be involved in some aspect
of the ocular changes associated with visually guided ocular
growth.
METHODS
Animals:  White  Leghorn  cockerels  (Gallus  gallus)  were
obtained  as  two-day-old  hatchlings  from  Ideal  Breeding
Poultry Farms (Cameron, TX). Form deprivation myopia was
induced in two-day-old chicks by applying translucent plastic
goggles as previously described [21,22]. Briefly, chicks were
lightly anesthetized with isoflurane (Vedco Inc., St. Joseph,
MO). Hemispheric goggles, cut from the bottoms of 15 ml,
round bottom test tubes, were affixed to the feathers around
the  right  eye  of  each  chick  with  cyanoacrylate  adhesive.
Goggles remained in place for 10 days, after which time chicks
were  either  sacrificed  for  isolation  of  ocular  tissues  from
control and form-deprived eyes, or goggles were removed and
chicks  were  allowed  to  experience  unrestricted  vision
(recover) for one, four, or seven days. The left eyes of all the
chicks were never covered and were used as controls. Previous
studies have demonstrated that the rate of glycosaminoglycan
synthesis  in  the  posterior  sclera  and  the  rate  of  ocular
elongation  are  significantly  increased  following  two  days
form deprivation [22,23]. Upon restoration of unrestricted
vision (10−14 days of form deprivation), glycosaminoglycan
synthesis  in  the  posterior  sclera  and  the  rate  of  ocular
elongation drop to their lowest levels following four and seven
days of recovery, respectively [9,22]. Based on these previous
studies, the time courses for the present study were designed
to identify molecular changes in ocular tissues induced early
in the recovery process, as well as changes that are manifested
when the eye has dramatically slowed its rate of vitreous
chamber  elongation  and  has  demonstrated  choroidal
thickening. Additionally, ocular tissues were harvested from
untreated normal eyes of 10-day-old chicks for comparison of
ATH expression in ocular tissues (n=3).
Birds were housed in temperature-controlled brooders on
a  12  h:12  h  light-dark  cycle,  allowed  food  and  water  ad
libitum, and checked twice a day. The chicks were maintained
and used in accordance with the Animal Welfare Act and
National  Institutes  of  Health  Guidelines  and  the  ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research. All procedures adhered to the Institutional Animal
Care  and  Use  Committee  of  the  University  of  Oklahoma
Health Sciences Center.
Microarray analyses: For microarray analyses, retina–RPE–
choroid complexes were isolated and pooled separately from
six treated and contralateral control chick eyes following one
and four days of recovery. This was done by using TRIzol
reagent  according  to  the  manufacturer’s  instructions
(Invitrogen, Carlsbad, CA) and RNeasy MinElute CleanUp
(Qiagen, Valencia, CA). RNA was then amplified and labeled
using Amino Allyl message Amp aRNA kit (Qiagen). RNA
concentration  and  purity  were  determined  by  ultraviolet
spectrophotometry at 260 nm and 280 nm and then transferred
for  microarray  analysis  to  the  Fred  Hutchinson  Cancer
Research Center (FHCRC) Genomics Resource DNA Array
Laboratory  (Seattle,  WA).  Following  amplification  and
labeling of RNA, microarray analyses were conducted using
a chicken immune system 4000 gene microarray (FHCRC
Genomics Resource).
Production and use of this chicken immune system glass
slide cDNA microarray have been previously described [24,
25]. Briefly, the array was composed of clones from three
expressed sequence tag (EST) libraries: about 1,800 clones
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lymphoma  cell  line,  about  1,200  clones  from  a  chicken-
activated T-cell library [26], and about 500 clones from a
normal  two-week  bursal  library,  DKFZ426  [27].  The
complete array contained 3451 cDNAs representing about
2,700 different genes. Since cDNAs were derived from EST
libraries, clones with the same gene identification usually
contained different partial cDNA sequences and were located
in  different  portions  of  the  spotted  array.  The  different
representatives of the same gene served to help determine
experimental consistency of expression results for individual
genes of interest and were therefore included in the summary
of microarray results (Table 1).
Reference  Cy5  dye-labeled  cDNA  from  retina/RPE/
choroid complexes for 1-day recovering eyes was mixed with
Cy3  labeled  cDNA  from  contralateral  control  eyes  and
simultaneously  hybridized  to  microarrays  under  glass
coverslips for 16 h at 63 °C. Additionally, dye swap control
experiments were performed in which Cy3 dye-labeled cDNA
from  retina/RPE/choroid  complexes  for  1-day  recovering
eyes was mixed with Cy5 labeled cDNA from contralateral
control eyes before hybridization. Fluorescent array images
were collected for both Cy3 and Cy5 by using a GenePix
4000A fluorescent scanner (Axon Instruments, Foster City,
CA), and image intensity data were extracted and analyzed by
using Genepix pro 3.0 analysis software. Normalization of the
Cy5 to Cy3 signal in each experiment was determined by
assuming equal global hybridization of test and reference
probes to DKFZ426 and T-cell library clones on the array.
Genes  in  the  retina–RPE–choroid  of  treated  eyes  that
exhibited ≥ 2.5 fold expression differences (upregulated or
downregulated) were considered significant and included in
Appendix 1.
Real-time  PCR:  Total  RNA  was  extracted  from  isolated
retina–RPE, choroid, sclera, and extraocular muscle of both
eyes of three normal 10-day-old chicks. Extraocular muscle
was included as a positive control for ATH expression, since
parvalbumins are known to be expressed in skeletal muscle
and ATH is considered a parvalbumin [28–30]. Briefly, 5 mm
punch biopsies were obtained from the posterior pole of each
eye in such a way that they contained retina, RPE, choroid,
sclera, and extraocular muscle. These were placed in a Petri
dish containing phosphate buffered saline (137 mM NaCl, 2.7
KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4, pH 7.4; PBS).
With the aid of a binocular dissection scope, the retina and
RPE were removed as a sheet from the 5-mm punch with a
small spatula and snap froze the sheets in microfuge tubes in
liquid nitrogen. Occasionally, small pieces of RPE would
adhere to the choroid, and these were removed by gentle
brushing  with  a  sable  brush  and  rinsing  with  PBS.  PBS
containing  the  RPE  was  collected  and  added  to  tubes
containing  retina–RPE.  Forceps  were  used  to  remove  the
choroid and extraocular muscle from the scleral punches, and
choroid,  sclera,  and  muscle  were  placed  separately  in
microfuge  tubes  and  snap  frozen  in  liquid  nitrogen.  The
dissection  of  the  sclera  from  extraocular  muscle  is
straightforward since the sclera consists of cartilage, which is
readily and effectively isolated from the extraocular muscle
and other ocular tissues. However, we cannot rule out the
possibility of cross contamination of mRNA between some
ocular tissues, such as the RPE and choroid. Total RNA was
isolated  from  each  ocular  tissue  using  TRIzol  reagent
(Invitrogen)  and  RNeasy  MiniElute  CleanUp  (Qiagen).
Scleral punch biopsy specimens were pulverized under liquid
nitrogen using a Dounce tissue grinder mounted to a drill. All
tissues  (retina–RPE,  choroid,  pulverized  sclera  and
extraocular muscle) were then homogenized in 1 ml TRIzol
Reagent using a VirTis homogenizer (Gardiner, NY) before
5  min  incubation  at  room  temperature  (RT)  and  200  μl
chloroform  treatment  for  dissociation  of  nucleoprotein
complexes. The tubes were vigorously shaken by hand for 15
min,  then  incubated  at  RT  for  2  min,  before  they  were
centrifuged  at  12,000x  g  for  15  min  at  4  °C.  Following
centrifugation, the upper aqueous (RNA) phase was collected
into a fresh tube then precipitated into a gel-like pellet with
500 μl isopropyl alcohol by incubating for 10 min at RT and
centrifugation at 12,000x g for 15 min at 4 °C. After removal
of the supernatant, the RNA pellet was washed once with 1 ml
75% ETOH by centrifugation at 7,500x g for 5 min at 4 °C.
The RNA pellet was dried by air for 10 min before the RNA
was dissolved in 100 μl RNase-free water and incubated for
10 min at 60 °C. RNA was stored at −80 °C until use. RNA
concentration and purity were determined at an optical density
ratio  of  260:280  using  the  Nanodrop®  ND-1000
spectrophotometer  (NanoDrop  Technologies,  Wilmington,
DE).  cDNA  was  generated  from  total  RNA  by  reverse
transcription, and real-time PCR was performed as previously
described [28]. Briefly, samples from each bird were analyzed
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TABLE 1. REAL-TIME PCR GENE PRIMERS.
Gene GenBank Primer
Avian Thymic Hormone (ATH) M94894.1 F: TGAAGGCATAACAGCGTGAG
R: GGATGGAAAGCCTGAACAAA
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) NM_204305 F: TGCTAAGGCTGTGGGGAAAGTC
R: CAAAGGTGGAGGAATGGCTGTCin triplicate using gene-specific chicken primers together with
SYBR Green (Molecular Probes, Eugene, OR) in a 96 well
plate format, using an i-Cycler iQTM Multi-Color Real Time
PCR  Detection  System  (Bio-Rad,  Hercules,  CA).  Primers
were  selected  from  chick  sequences  of  ATH  and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) using
BLAST and Primer3 and ordered from Sigma-Genosys (St.
Louis, MO; Table 1). The chicken GAPDH gene was used as
a control to normalize for variation in starting cDNA between
samples.  For  both  ATH  and  GAPDH,  denaturation  was
performed for 45 s at 95.0 °C, primer annealing for 45 s at
62 °C, and extension was performed for 60 s at 72.0 °C.
Relative levels of ATH gene expression were determined for
the retina–RPE, choroid, sclera, and extraocular muscle using
the mean normalized expression (MNE) values as previously
described [28,29]. Briefly, MNE values are calculated as the
ratio of the efficiency and mean threshold cycles of the PCR
reaction of the reference gene, G3PDH, to the efficiency and
mean threshold cycles of the target gene, ATH. The MNE is
calculated from an exponential equation where the values for
the efficiencies of the reference and target genes serve as the
base and the mean cycle thresholds of the reference and target
gene are the exponents. In this method, the expression levels
of the gene of interest can be normalized to a housekeeping
gene  to  correct  for  differences  in  starting  mRNA
concentrations between samples. Correct product size was
confirmed by DNA agarose gel, and lack of primer dimer
formation was verified by melt curve analysis.
Immunohistochemistry:  Immunohistochemical  detection  of
ATH was performed as follows. One chick was form vision-
deprived in the right eye for 13 days followed by a four-day
period of unrestricted vision in the treated eye. At the end of
the recovery period, the chick was anesthetized with 0.8%
isoflurane (Vedco Inc.) inhalation anesthesia in oxygen then
perfused  through  the  left  ventricle  with  approximately
1,000 ml PBS, pH 7.4, at roughly18–20 °C to clear blood from
ocular tissues. After the perfusion, the eyes were enucleated,
opened at the equator, and a 5 mm punch biopsy that contained
retina,  RPE,  choroid,  sclera,  and  extraocular  muscle  was
obtained at the posterior pole of the treated and contralateral
control eyes. Ocular tissue punches were fixed in 4 °C in 4%
paraformaldehyde in 0.1 M phosphate buffer pH 7.4, followed
by immersion in 30% sucrose in phosphate buffer for 16–20
h at 4 °C. Tissue punches were then embedded and frozen in
O.C.T.  embedding  compound  (Tissue-Tek,  Elkhart,  IN).
Serial cross-sections of each tissue punch were cut into 10-μ-
thick sections using a cryostat microtome and collected on
glass slides.
For immunocytochemical localization of ATH in chick
ocular tissues, cryostat sections were rinsed in PBS, and then
incubated for 30 min at RT in incubation buffer that consisted
of 1% BSA (Sigma), 0.2% Triton X-100, and 0.004% sodium
azide in PBS. Sections were incubated overnight at 4 °C with
mouse  anti-ATH  monoclonal  antibody  (obtained  as  a
generous  gift  from  Dr.  Michael  Henzl,  University  of
Missouri-Columbia, Department of Biochemistry, Columbia,
MO) diluted 1:500 in incubation buffer. For negative controls,
tissue sections were incubated in 2 μg/ml nonimmune mouse
immunoglobulin  (Sigma)  instead  of  the  ATH  antibody.
Additional preabsorption controls were performed in which
the anti-ATH antibody was incubated overnight at 4 °C with
2  μM  of  purified  chicken  ATH  [30]  (also  obtained  as  a
generous  gift  from  Dr.  Michael  Henzl)  before
immunolabeling  fixed  cryostat  sections  of  chick  ocular
tissues.  Following  overnight  incubation  with  the  primary
antibody, sections were rinsed in PBS, and incubated for 30
min at RT in 5 μg/ml of AlexaFluor 488 (green) or AlexaFluor
568  (red)  conjugated  to  rabbit  anti-mouse  antibody
(Molecular Probes). Sections were rinsed in PBS and then
incubated for 10 s at RT with 0.0005% DAPI nuclear stain,
followed by a final rinse in PBS. Coverslips were mounted
onto the slides with Prolong Gold Antifade reagent containing
DAPI  (Invitrogen),  and  the  immunolabeled  sections  were
examined under an Olympus Fluoview 1000 laser-scanning
confocal  microscope  (Center  Valley,  PA).  The  anti-ATH
antibody  used  in  these  studies  has  been  previously
demonstrated to be specific for ATH, and does not cross-react
with other chicken parvalbumins [30].
Western blot analysis: Chick retina–RPE, choroid, and sclera
were isolated separately from 5 mm punch biopsy specimens
obtained  from  the  posterior  poles  of  form-deprived  eyes,
recovering  eyes  (one,  four,  and  seven  days),  contralateral
control eyes, and normal eyes (n=3 treated and contralateral
control eyes for each condition). Total protein was extracted
separately from each tissue by vigorous mixing in 100 μl/
extract of 2% SDS. Suprachoroidal fluid was collected from
the  central  posterior  pole  of  enucleated  chick  eyes  as
previously described [10]. This was done by inserting the
needle,  bevel  side  up,  just  beneath  the  sclera,  in  the
suprachoroidal space and withdrawing 10–40 µl of fluid from
each eye. A larger volume (30–40 μl) of suprachoroidal fluid
was  generally  obtained  from  recovering  eyes,  while  10–
20 μl of fluid was usually obtained from control and form-
deprived eyes. Individual suprachoroidal fluid samples were
centrifuged at 16,870x g at 4 °C for 15 min to pellet blood
cells and any cellular debris. However, it is possible that cells
damaged during collection of suprachoroidal fluid could have
released cellular contaminants into the fluid that may not be
removed by centrifugation. Total protein in individual tissue
extracts  and  suprachoroidal  fluid  was  determined  by
employing the microBCA protein assay with a 96 well plate
format  (Pierce  Biotechnology,  Rockford,  IL).  Protein
concentration was determined by measuring absorbance at
570 nm with comparison to protein standards (BSA; 0.5–
200 μg/ml). Aliquots of protein extracts (8 μg total protein)
were directly applied to 10% Bis-Tris Gel NuPAGE™ SDS–
PAGE gels (Invitrogen). Gel samples were electrophoresed
under  reducing  conditions  and  electroblotted  onto  a
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(XCELL  Sureback™  Electrophoresis  Cell,  Invitrogen)  or
stained with SimplyBlue™ SafeStain (Invitrogen) according
to the manufacturer’s instructions. Blots were probed for 4 h
at RT with mouse anti-chicken ATH monoclonal antibody at
a  1:500  dilution  in  blocking  buffer  composed  of  PBS
containing  0.1%  Tween-20  and  0.2%  I-Block  (Tropix,
Bedford, MA). This was followed by incubation with rabbit
anti-mouse  IgG  (whole-molecule)  conjugated  to  alkaline
phosphatase (Sigma) at a dilution of 1:1,000 for 1 h at RT.
Between incubations the blot was washed three times for 10
min per wash with 1× PBS containing 0.05% Tween-20. CDP-
Star ® Ready-to-Use with Nitro-Block II™ (Tropix) was
added to the blot for 5 min and then exposed on film. For
quantification of ATH, film exposures were adjusted for each
blot  (each  tissue)  to  be  in  the  linear  range  of  detection.
Digitized images of the developed films were obtained using
a flatbed scanner, and densitometry was performed using NIH
Image version 1.63 (National Institutes of Health, Bethesda,
MD).
Statistical analysis: Comparisons of ATH protein expression
differences between treated and contralateral control eyes in
five treatment groups were made using the Kruskal–Wallis
ANOVA nonparametric test for mean treatment effect across
groups. Additionally, pairwise testing using the Wilcoxon
signed-rank  tests  was  used  to  measure  ATH  expression
between pairs of treated and control eyes. Statistical analyses
were  performed  with  the  assistance  of  GraphPad  Prism
version 4.03 for Windows (GraphPad Software, San Diego,
CA) and GB-STAT for Macintosh (Dynamic Microsystems,
Inc., Silver Spring, MD).
RESULTS
Microarray  analysis  of  retina–RPE–choroid  during
recovery: Analysis of the 4,000 gene microarrays identified a
total  of  30  loci  representing  14  genes  which  were  either
upregulated or downregulated in experimental eyes by at least
a 2.5 fold change over contralateral control eyes (Appendix
1). Following one day of recovery, only the expression of one
gene on our microarray, ATH (accession number M94894.1),
was  highly  upregulated  (+12.3  fold)  and  no  genes  were
downregulated in their expression by ≥2.5 fold. Following
four days of recovery, 10 genes were downregulated and one
gene, ovotransferrin, was upregulated.
ATH expression in ocular tissues: Due to the relatively high
level of upregulation of ATH in the retina–RPE–choroid of
chick eyes following one day of unrestricted vision (Appendix
1),  and  since  ATH  expression  had  not  been  previously
identified  in  ocular  tissues,  real-time  PCR  was  used  to
compare relative levels of ATH mRNA in chick retina–RPE,
choroid,  sclera,  and  extraocular  muscle  (Figure  1A).
Expression levels of ATH were calculated in chick retina–
RPE, choroid, sclera and extraocular muscle with the cycle
threshold  values  normalized  to  the  housekeeping  gene,
GAPDH using the MNE. ATH expression levels were highest
in  extraocular  muscle  (MNE=2.85±0.335)  and  sclera
(1.24±0.149),  and  substantially  lower  in  the  retina–RPE
(0.0032±0.0004)  and  choroid  (0.039±0.0036).  Ethidium
bromide-stained agarose gels of real PCR products were run
to  verify  the  correct  size  and  amplification  of  ATH  and
GAPDH  in  chick  extraocular  muscle  over  temperatures
ranging  66–55  °C  (Figure  1B).  Although  isolation  of  the
retina–RPE,  choroid,  sclera,  and  extraocular  muscle  is
straightforward, the possibility exists for cross-contamination
of cellular material and mRNA between the RPE and choroid,
thereby altering the relative levels of ATH mRNA in these
tissues somewhat from that which occurs in vivo.
ATH protein in chick ocular tissues: A specific monoclonal
antibody generated against chicken ATH (Michael Henzl,
University  of  Missouri-Columbia,  Department  of
Biochemistry,  Columbia,  MO)  was  used  in  western  blot
analysis  to  examine  the  distribution  of  ATH  in  the
suprachoroidal fluid, serum, retina, brain, choroid, sclera, and
extraocular muscle of the chick eye (Figure 2). A single band
of approximately 11.5 kDa could be identified in chick protein
extracts of choroid, retina, sclera, and extraocular muscle. No
labeling was observed of bands at Mr other than 11.5 kDa
(Figure 2). Additionally, ATH was detected in suprachoroidal
fluid. ATH was nearly undetectable in serum, and no ATH
immunopositive bands were seen in the chick brain. Although
very low levels of ATH were detected in the serum in the
present study, a previous study identified ATH in the blood
of chicks [31]. Therefore, for immunolocalization studies,
chicks were perfused with approximately 1,000 ml PBS to
clear blood from ocular tissues.
Confocal  microscopy  enabled  detection  of  specific
immunolabeling for ATH in the retina, choroid, and fibrous
layer  of  the  chick  sclera  (Figure  3  and  Figure  4).  ATH
immunolabeling was mostly detected in cell bodies located on
the inner 1/3 to 1/2 of the inner nuclear layer (INL) of the
retina. Punctate labeling was also detected in the proximal and
distal sublaminae of the inner plexiform layer (IPL) which
most likely represents the synaptic processes of ATH-positive
cells of the INL. In some cases, ATH labeling could be seen
in cell processes extending from the amacrine cell bodies to
the  synaptic  terminals  in  the  IPL  (Figure  4A,  inset).
Comparison  with  nonimmune  IgG  controls  indicated  that
ATH-positive labeling in the photoreceptor inner segments
represented nonspecific labeling of lipid droplets possibly due
to absorption of the fluorophore into the lipid matrix of the
droplets  or  nonspecific  immunolabeling  (Figure  3).  ATH
labeling was observed throughout the choroidal stroma, the
choriocapillaris, and choroidal portion of Bruch’s membrane
of control and recovering eyes (Figure 3B and Figure 5C). In
recovering eyes, the choroid was substantially thickened, and
ATH  could  be  seen  distributed  throughout  the  choroidal
stroma (Figure 3C and Figure 4D). Comparison with negative
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RPE portion of Bruch’s membrane. However, the presence of
intracellular ATH in the RPE cannot be excluded due to the
presence of pigment in mid- to apical parts of the cells which
might obscure ATH immunoreactivity. Intense ATH labeling
was detected in the fibrous layer of the chick sclera, but not
in the cartilaginous layer (Figure 3 and Figure 5). To verify
the specificity of the anti-ATH antibodies for ATH in chick
ocular tissues, we preincubated ATH antibodies with 2 μM
chick ATH before immunolabeling (Figure 6B, ATH protein
block)  and  compared  immunolabeling  patterns  were
compared between sections treated with anti-ATH (Figure
6A), ATH protein block (Figure 6B), and nonimmune mouse
IgG  (Figure  6C).  No  immunoreactivity  was  observed  in
fibrous sclera, choroids, and retina (not shown) using ATH
protein  blocked  antibodies,  indicating  the  absence  of
nonspecific  immunolabeling  by  anti-ATH  in  chick  ocular
tissues.
Changes  in  ATH  protein  during  recovery  from  induced
myopia: Total accumulated ATH was measured in retina–
RPE, choroid, suprachoroidal fluid, and sclera of normal,
untreated chick eyes, treated eyes following 10 days of form
deprivation,  and  following  one,  four,  or  seven  days  of
unrestricted vision with prior form deprivation for 10 days
(recovery),  and  contralateral  control  eyes  (Figure  7A-F).
Equivalent amounts of total protein (8 μg/lane) extracted from
tissues  or  suprachoroidal  fluid  were  electrophoresed  and
transblotted onto nitrocellulose for Western detection using
anti-ATH  together  with  anti-mouse  IgG  conjugated  to
alkaline phosphatase. Using this method, we could detect
purified chicken ATH [30] in the linear dynamic range from
20 to 500 ng (data not shown). Representative blots of ATH
in retina–RPE, choroid, sclera, and suprachoroidal fluid in
control and treated eyes following four days of recovery are
shown  in  Figure  7E.  A  substantial  increase  in  ATH  was
detected in choroid extracts from treated eyes following four
days  of  recovery  as  compared  to  contralateral  controls
Figure  1.  Real  time  RT–PCR
quantification of ATH in chick ocular
tissues.  Steady-state  levels  of  ATH
mRNA  were  measured  in  the  retina–
RPE,  choroid,  sclera,  and  extraocular
muscle  using  chick  gene-specific
primers (Table 1). A: The average mean
normalized expression (MNE) of ATH
was calculated in each ocular tissue of
three untreated 10 day old chicks. All
reactions  were  run  in  triplicate  and
normalized  to  the  reference  gene,
GAPDH.  B:  Shown  are  ethidium
bromide gels of real-time PCR products
of  ATH  and  GAPDH  in  chick
extraocular  muscle  over  temperatures
ranging  66–55  °C.  Mr:  PhiX174RF
DNA/HaeIII molecular weight ladder,
Lane 1: 66.0 °C, Lane 2: 65.2 °C, Lane
3: 63.9 °C, Lane 4: 61.8 °C, Lane 5:
59.0  °C,  Lane  6:  57.2  °C,  Lane  7:
55.8 °C, Lane 8: 55.0 °C.
Figure 2. ATH protein detection in the
chick  eye.  Western  blot  analysis
identified the presence of ATH in the
suprachoroidal  fluid  (supra),  retina–
RPE (ret), choroid (ch), sclera (scl), and
extraocular muscle (eom) of the chick
eye.  An  ATH-immunopositive  band
was barely detectible in serum (serum),
and no ATH was detected in chick brain
(br). Total protein from each sample was
determined using the BCA assay, and 8
μg total protein was loaded into each
well.
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783(p<0.05; Wilcoxon signed-rank test). The increase in ATH
expression in treated eyes following 4 days of recovery was
significantly different from that of all other treatment groups
(p<0.05; Kruskal–Wallis ANOVA) however, due to the small
Figure 3. Localization of Avian Thymic Hormone (ATH) labeling in posterior ocular tissues of control and recovering chick eyes. Monoclonal
antibodies specific for ATH (obtained from Michael Henzel, University of Missouri, Columbia, MO) were used together with AlexaFluor
488-conjugated rabbit anti-mouse immunoglobulin to localize ATH in chick ocular tissues. A: ATH immunolabeling of a control eye
demonstrated intense labeling in the fibrous scleral layer (FS) and the choroid. Additionally, ATH was detected in a subpopulation of cell
bodies located in the inner nuclear layer (INL) and in two sublaminae of the inner plexiform layer, most likely representing the synaptic
processes of ATH-positive cells of the INL. B: IgG control section of a control eye is shown where non-immune mouse IgG was used in the
first incubation, followed by incubation in AlexaFluor 488-conjugated rabbit anti-mouse immunoglobulin. Fluorescence of lipid droplets in
the photoreceptor inner segments (*) and in the nerve fiber layer is nonspecific. Nuclei were stained with DAPI (blue). C: ATH distribution
in a recovering eye was similar to that of controls, with specific immunolabeling in the fibrous sclera, as well as throughout the markedly
thickened choroid, cells of the INL and sublaminae of the inner plexiform layer (IPL). Vertical bars indicate thickness of choroid layer in
control (3A) and recovering (3C) eyes. Abbreviations: cartilaginous sclera (CS), outer nuclear layer (ONL), ganglion cell layer (GCL). Scale
bar (A–C) equals 100 μm.
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Figure 4.  Distribution  of ATH  in  the
retina of control and recovering chick
eyes. A: ATH immunolabeling in the
retina  of  a  control  chick  eye  ATH
immunoreactivity  can  be  seen  in  a
subpopulation of amacrine cells in the
inner nuclear layer (INL) as well as in
proximal and distal sublaminae in the
inner  plexiform  layer  (IPL;
arrowheads).  Nonspecific  labeling  is
present  in  lipid  droplets  in  the
photoreceptor inner segments and in the
nerve  fiber  layer  (*).  Inset:  A
presumptive  ATH-immunoreactive
bistratified  amacrine  cell  is
demonstrated with a process appearing
to extend to the distal IPL (arrowhead).
Scale bar represents 50 μm. B: ATH
immunolabeling is shown in the retina
of a recovering chick eye. Similar to the
control eye, ATH immunoreactivity can
be seen in a subpopulation of amacrine
cells in the INL as well as in proximal
and  distal  sublaminae  in  the  IPL
(arrowheads). C: IgG control section of
the  retina  of  a  control  eye  is  shown,
where  non-immune  mouse  IgG  was
used in the first incubation, followed by
incubation  in  AlexaFluor  488-
conjugated  rabbit  anti-mouse
immunoglobulin.  Scale  bar  (A–C)
represents 50 μm.sample size used (n=3), important treatment differences in
other  groups  may  have  gone  undetected  (Figure  7B).  No
significant differences were detected in ATH concentration in
treated eyes as compared with controls in retina–RPE (Figure
7A), sclera (Figure 7C), or suprachoroidal fluid (Figure 7D)
of  normal  eyes,  form  deprived  eyes,  or  recovering  eyes.
Choroidal expression of ATH was re-evaluated by western
blot analyses in six additional birds following four days of
recovery as compared with contralateral controls to verify
increased  expression  in  treated  eyes  as  compared  with
controls (p<0.05; Wilcoxon signed-rank test) (Figure 7E).
DISCUSSION
In  an  attempt  to  elucidate  the  retina-to-sclera  chemical
cascade involved in emmetropization, we examined changes
in retina–choroid–RPE gene expression in eyes in which the
Figure 5. Distribution of ATH in the sclera and choroid of control and recovering chick eyes. Monoclonal antibodies specific for ATH were
used together with AlexaFluor 488-conjugated rabbit anti-mouse immunoglobulin to localize ATH in sclera and choroid of control and
recovering eyes. A: Intense ATH immunolabeling is detected in the fibrous sclera (FS) and in perivascular and extravascular regions of the
choroid. ATH was absent in the cartilaginous scleral layer (CS). B: IgG control section of the sclera and choroid of a control eye, where
nonimmune  mouse  IgG  was  used  in  the  first  incubation,  followed  by  incubation  in  AlexaFluor  488-conjugated  rabbit  anti-mouse
immunoglobulin. C: ATH immunolabelling in the sclera of a recovering chick eye is shown in a region artifactually separated from the choroid.
ATH can be seen localized in the outer fibrous sclera (FS) as well as in the thin inner fibrous sclera on the choroidal side of the sclera. D:
ATH immunolabeling in the choroid of a recovering chick eye is shown. ATH can be seen throughout the stroma of the markedly expanded
choroid  and  on  the  choroidal  side  of  Bruch’s  membrane  (arrow),  but  is  absent  in  the  RPE.  Nuclei  were  stained  with  DAPI  (blue).
Choriocapillaris is abbreviated CC. Scale bar (A–D) represents 50 μm.
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786rate of ocular growth was dramatically slowed due to imposed
myopic defocus as a result of prior form deprivation (recovery
from form deprivation myopia). Analysis of a 4,000 gene
microarray identified the expression of one gene, ATH, to be
upregulated in the retina–RPE–choroid following one day of
recovery as compared with contralateral control eyes. The
elevation  of  ATH  gene  expression  following  one  day  of
recovery suggests that this hormone is involved in immediate
retinal–choroidal signaling events initiated by restoration of
unrestricted  vision.  Following  four  days  of  recovery,  one
gene,  ovotransferrin,  was  significantly  upregulated  in  the
retina–RPE–choroid of recovering eyes as compared with
contralateral control eyes. This finding is consistent with our
previous  finding  that  ovotransferrin  protein  synthesis  is
significantly  increased  in  isolated  choroids  during  the
recovery from induced myopia [9]. The consistency of these
two  independent  findings  supports  the  validity  of  these
microarray results. No genes were downregulated following
one  day  of  recovery.  However,  following  four  days  of
recovery, 10 genes were downregulated by ≥ 2.5 fold. The
finding that several housekeeping genes including GAPDH,
heat shock cognate 70, and ribosomal protein large P0 were
downregulated by ≥ 2.5 fold at multiple loci on the microarray
suggests that a general downregulation of gene expression
may occur in the retina–RPE as well as choroid after four days
of recovery from induced myopia. It should be noted that the
chick gene microarray used in the present study represented
4,000  genes  with  an  emphasis  on  genes  expressed  in  the
chicken immune system and therefore does not provide a
comprehensive list of all changes in gene expression that
might be occurring in the retina, RPE, or choroid during the
recovery  from  induced  myopia.  Additionally,  since
microarray analyses were performed on RNA pooled from
three  complex  tissues  (retina,  RPE,  and  choroid),  the
possibility exists for false negatives due to opposite, mutually
canceling effects of gene expression in two or more cell types
contained in these ocular tissues. Moreover, the use of the
contralateral untreated eye as the control eye may result in
additional false negatives in our analyses, as some aspects of
the ocular response to imposed plus defocus are also observed
in the contralateral untreated eyes [32–35].
Due to the uniquely increased gene expression of ATH in
the  retina–RPE–choroid  of  eyes  following  one  day  of
recovery as detected by microarray analysis, the present study
was aimed at evaluating the protein expression of ATH in
chick  ocular  tissues  of  normal  eyes,  form-deprived  eyes,
recovering eyes, and contralateral eyes. ATH was originally
identified as a thymus-specific antigen [32] that is synthesized
and secreted by epithelial cells in the thymic cortex [30,36].
Based on its protein and gene sequences [37,38], ATH is
described as a parvalbumin having a molecular weight of
11.7 kDa and three helix–loop–helix (EF-hand) motifs, two
of which are functional for binding calcium [39,40]. On the
basis of their metal ion-binding properties, parvalbumins are
generally considered cytosolic Ca2+ buffers and transporters,
and  play  a  role  in  skeletal  muscle  contraction  [41]  and
neuronal de-excitation [42]. ATH has also been shown to
function in T-cell maturation and differentiation in the thymus
in a paracrine manner [43,44]. ATH has been shown to induce
the expression of T cell surface markers in bone marrow
precursor cells [45] and enhance the graft-versus-host reaction
in chick embryos treated with peripheral blood mononuclear
cells  previously  incubated  with  ATH,  possibly  due  to
activation of γδ T lymphocytes [31].
Steady-state mRNA concentrations of ATH relative to
that of the housekeepjng gene GAPDH, were compared in
chick  ocular  tissues  using  quantitative  real  time  reverse
transcription PCR. ATH mRNA levels were lowest in the
Figure 6. Specificity of anti-ATH on sections of chick ocular tissues. Fixed cryostat sections of chick sclera and choroid were incubated with
A) monoclonal anti-ATH antibody (ATH positive), with B) anti-ATH antibody that was preincubated with 2 μM recombinant chick ATH
(ATH protein block), or with C) nonimmune mouse IgG (IgG control) followed by incubation in anti-mouse IgG conjugated to AlexaFluor
568 (red). No specific immunoreactivity is observed in fibrous sclera (FS) and choroid when antibodies were preincubated with ATH, indicating
the specificity of the anti-ATH antibodies for ATH in chick ocular tissues, cartilaginous sclera is abbreviated as CS.
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ATH expression was orders of magnitude higher in the sclera
(roughly 390 fold) and extraocular muscle (roughly 900 fold)
as compared with that in the retina–RPE.
Following confirmation of ATH gene expression in chick
ocular tissues, we evaluated ATH protein expression using a
specific monoclonal antibody generated against chick ATH
[30]. ATH was detected in the retina, choroid, suprachoroidal
Figure 7. ATH protein accumulation in
posterior chick ocular tissues from eyes
in various growth states. Retina–RPE,
choroid, sclera, and suprachoroidal fluid
were harvested from the posterior poles
of  10-day-old  untreated,  normal  eyes
(N),  following  10  days  of  form
deprivation (FD), and following 1, 4,
and 7 days of unrestricted vision with
prior form deprivation for 10 days (1
day,  4  day,  and  7  day  recovery,
respectively) together with tissues from
contralateral control eyes. Total protein
(8  μg)  from  each  tissue  extract  was
separated  by  SDS–PAGE,  and  ATH
protein  expression  was  detected  by
western  blot  analysis.  The  11.5  kDa
band from each sample was quantified
by  densitometry  using  NIH  Image  v.
1.63.  Bars  represent  the  integrated
optical density (IOD) of ATH bands on
western blots from treated eyes minus
IOD  of  contralateral  controls  (mean
±SEM). A: ATH protein expression was
measured in the posterior retina/RPE. B:
ATH protein expression was measured
in the posterior choroid. A large increase
in  ATH  was  detected  in  choroids
following  4  days  of  recovery  as
compared with ATH levels in choroids
of  contralateral  controls.  C:  ATH
protein expression was measured in the
posterior  sclera.  D:  ATH  protein
accumulation was measured in aliquots
of suprachoroidal fluid isolated from the
posterior poles of enucleated eyes. E:
ATH protein expression was measured
in choroids following 4 days of recovery
and in contralateral control eyes (n=6
additional pairs of control and treated
eyes). F: Representative western blots
are shown of ATH protein in retina/RPE
(Ret), choroid (Chor), sclera (Scl), and
suprachoroidal fluid (Supra) in treated
(R) and control (C) eyes following 4
days  of  recovery.  Data  represent  the
mean±SEM for n=3 birds (3 pairs of
control and treated eyes for figures A-D
and n=6 pairs for figure E) in each group
*p<0.05.  Comparisons  between
recovering  and  contralateral  control
eyes  were  made  using  the  Wilcoxon
signed-rank test for paired data.
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788fluid, sclera, and extraocular muscle, but little to no ATH was
detected in serum or brain. Confocal microscopy enabled the
detection of abundant levels of ATH throughout the choroidal
stroma, choriocapillaris, and in the choroidal side of Bruch’s
membrane. Interestingly, the fibrous layer of the chick sclera
was intensely positive for ATH, while the cartilaginous layer
of the sclera was negative. It has been suggested that the
fibrous  layer  of  the  chick  sclera  is  comparable  to  the
mammalian  sclera,  while  the  cartilaginous  sclera  is  lost
through evolution [46–48]. The finding of ATH exclusively
in the fibrous sclera allows for speculation that ATH (or the
mammalian  ortholog)  may  play  a  role  in  the  growth  and
remodeling  of  the  mammalian  sclera.  Specific
immunolabeling for ATH was also detected in the cell bodies
and synaptic processes of a subset of neurons largely located
on the inner 1/3 to 1/2 of the INL with processes extending
into several sublaminae of the IPL. The retinal distribution of
ATH is similar to that previously described for parvalbumin
in the chick retina [49], where parvalbumin-immunoreactive
amacrine cells located in the inner margin of the INL could
be  seen  branching  to  multiple  lamina  of  the  IPL.  The
distribution of ATH in the chick retina is also similar to that
of bistratified rod amacrine cells (AII) amacrine cells recently
described in the bat retina [50], although it is unlikely that
ATH-positive neurons are AII amacrine cells, as AII amacrine
cells have not been previously described in the chicken. The
size and location of the ATH-immunoreactive cells are also
similar to that described for enkephalin-, neurotensin- and
somatostatin-like immunoreactive (ENSLI) amacrine cells in
the chicken retina [51,52]. Interestingly, ENSLI cells have
been  demonstrated  to  have  a  light-dependent  pattern  of
activity [53] which has been shown by one laboratory to be
suppressed  by  visual  form  deprivation  [54],  but  was  not
confirmed by others [55]. Comparison of ATH levels in ocular
tissues and suprachoroidal fluid of treated and control eyes
indicated that ATH protein levels were significantly elevated
in the choroids of chick eyes following four days of recovery
as compared with contralateral control eyes. These results
suggest that the increased ATH mRNA levels detected by
microarray  analyses  of  retina–RPE–choroid  of  chick  eyes
following one day of recovery likely represent changes in ATH
gene  expression  exclusively  in  the  choroid.  Interestingly,
ATH levels returned to levels similar to controls by seven days
of recovery, suggesting a turnover of ATH from the choroidal
stroma. The finding of ATH in the suprachoroidal fluid also
suggests that ATH is circulated between the choroidal stroma
and the choroidal lymphatic channels in chick eyes during all
ocular growth states; however, it is also possible that cellular
contaminants obtained during the collection of suprachoroidal
fluid may have contributed to the ATH protein levels observed
in the suprachoroidal fluid. The peak of ATH accumulation
in the choroid following four days of recovery corresponds to
the significant increase in choroidal permeability [8,10] and
choroidal thickness [7,9] previously observed. It is unlikely
that the increase choroidal levels of ATH is a reflection of
increased  permeability  of  serum  derived  ATH,  as
immunolabeling for ATH in the choroidal stroma was intense
even when chicks were perfused in vivo with PBS to clear
tissues of serum. Moreover, levels of ATH in chick serum
were barely detectible by western blot analysis in this study.
The  increased  expression  of  choroidal  ATH  does
correlate  with  the  rapid  decrease  in  scleral  proteoglycan
synthesis  observed  during  the  deceleration  of  ocular
elongation that occurs during the recovery from myopia [9,
22]. It is therefore tempting to speculate that secreted ATH
from the choroid may regulate scleral extracellular matrix
changes  that  occur  during  the  recovery  from  myopia.
However, preliminary experiments testing the direct effect of
ATH on scleral proteoglycan synthesis in vitro suggest that
ATH has no effect on scleral proteoglycan synthesis (data not
shown).
Oncomodulin, a mammalian protein homologous to ATH
(54% identity) [56], has been suggested to be synthesized and
secreted by macrophages. Oncomodulin has been suggested
to act as a potent growth and regeneration factor for retinal
ganglion cells and peripheral sensory neurons [57], although
a more recent study indicates that this is not the case [58]. It
is  therefore  possible,  that  circulating  macrophages  may
accumulate in extravascular locations in the choroid during
periods  of  increased  permeability  and  secrete  ATH
throughout the choroidal stroma.
In summary, the results of the present study show that
ATH is expressed in the chick retina, choroid, sclera, and
extraocular  muscle,  with  highest  mRNA  and  protein
expression  levels  in  the  sclera  and  extraocular  muscle.
Microarray and western blot results suggest that ATH mRNA
and protein expression are increased by choroidal cells early
during recovery from induced myopia, when ocular growth
rates are rapidly decelerating. Although the function of ATH
in the chick choroid is unknown, based on its high affinity for
Ca2+  and  its  role  as  an  endogenous  Ca2+  buffer  [59]  it  is
possible  that  ATH  may  participate  in  the  contraction/
relaxation  of  extravascular  smooth  muscle  located  in  the
choroidal stroma or be involved in modulation of synaptic
transmission  within  the  network  of  intrinsic  choroidal
neurons. We speculate that regulation of these functions may
play a role in modulating choroidal thickness and permeability
during the recovery from induced myopia [60,61]. Although
ATH protein levels were similar in the retina–RPEs of normal,
myopic,  recovering,  and  contralateral  eyes,  the  distinct
immunolabeling pattern of relatively few neurons in the inner
portion  of  the  INL  may  provide  a  useful  marker  for  this
population of cells in future immunocytochemical studies of
chick retinas in a variety of ocular growth states.
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791Appendix  1.  Summary  of  microarray  analysis  of  retina–RPE–choroids
during recovery from myopia.
To access the table, click or select the words “Appendix
1.” This will initiate the download of a pdf that contains the
table.
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